Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | iodixanol | 3724 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | doxazosin | 3157 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | doxazosin | 3157 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | doxazosin | 3157 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | doxazosin | 3157 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | doxazosin | 3157 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | doxazosin | 3157 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | doxazosin | 3157 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | doxazosin | 3157 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | doxazosin | 3157 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | doxazosin | 3157 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | doxazosin | 3157 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | doxazosin | 3157 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | doxazosin | 3157 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | mometasone | 441335 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mometasone | 441335 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mometasone | 441335 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | mometasone | 441335 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | mometasone | 441335 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | mometasone | 441335 | drug-path |